临床脑死亡患者临床实践的时间变化:单中心队列研究
这项回顾性单中心队列研究纳入2017-2025年冈山大学医院急诊ICU连续128例临床脑死亡患者,评估神经评估、重症管理和器官捐献流程的时间变化。结果显示,器官捐献讨论比例达85.9%,其中37.3%随后实施脑死亡后器官捐献。按日历年分析,皮质类固醇使用逐年增加(OR 1.64,95%CI 1.34-2.01,p<0.001),皮质类固醇和血管加压素启动更早;血管加压素使用及脑死亡兼容状态判定或首次捐献讨论时机无显著趋势。器官捐献讨论可能性随时间显著增加(OR 1.44,95%CI 1.17-1.79,p=0.001),在讨论可行的患者中敏感性分析仍显著(OR 2.11,95%CI 1.42-3.15,p<0.001)。
要点
- 在128例临床脑死亡患者中,85.9%的家庭进行了器官捐献讨论,37.3%随后实施脑死亡后器官捐献。
- 器官捐献讨论的可能性逐年增加(OR 1.44,95%CI 1.17-1.79,p=0.001),在讨论可行的患者中敏感性分析仍显著(OR 2.11,95%CI 1.42-3.15,p<0.001)。
- 皮质类固醇使用逐年增加(OR 1.64,95%CI 1.34-2.01,p<0.001),且皮质类固醇和血管加压素启动更早。
- 血管加压素使用、脑死亡兼容状态判定时机及首次器官捐献讨论时机未见显著时间趋势。
- 家属同意捐献的比例保持相对稳定,未因讨论机会增加而明显变化。
适用人群与场景
- 2017年1月至2025年12月期间在冈山大学医院急诊ICU连续收治的临床脑死亡患者,通过常规听性脑干反应测试在脑死亡兼容状态评估中识别。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为回顾性单中心队列研究,纳入128例临床脑死亡患者,来自日本冈山大学医院急诊ICU,时间跨度为2017年1月至2025年12月。
- 主要发现:器官捐献讨论在110例(85.9%)家庭中进行,41例(37.3%)随后实施脑死亡后器官捐献。
- 器官捐献讨论可能性逐年增加(OR 1.44,95%CI 1.17-1.79,p=0.001),在讨论可行的患者中敏感性分析仍显著(OR 2.11,95%CI 1.42-3.15,p<0.001)。
- 皮质类固醇使用逐年增加(OR 1.64,95%CI 1.34-2.01,p<0.001),且皮质类固醇和血管加压素启动更早;血管加压素使用、脑死亡兼容状态判定时机及首次器官捐献讨论时机无显著趋势。
- 家属同意捐献的比例保持相对稳定。
证据类型、等级与局限
- 证据类型为回顾性单中心队列研究;原文未给出证据等级或推荐强度;局限包括单中心、回顾性设计、描述性研究无法确定结构化多学科流程对时间趋势的贡献。
对床旁实践的改变
- 该研究提示在临床脑死亡患者中应重视并增加器官捐献讨论的机会,同时关注皮质类固醇和血管加压素的早期启动;但研究为描述性单中心回顾性设计,不能推断因果关系或改变具体药物剂量方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients considered clinically brain dead undergo neurological assessment and critical care management, along with discussions with their families regarding goals of care and, when appropriate, organ donation. However, how these clinical and organ donation-related practices have evolved over time remains poorly characterized in Japan. We aimed to evaluate temporal changes in neurological assessment, critical care management, and organ donation-related processes among patients considered clinically brain dead.
METHODS: We conducted a retrospective single-center cohort study including consecutive patients considered clinically brain dead in the Emergency ICU of Okayama University Hospital between January 2017 and December 2025. Patients were identified through routine auditory brainstem response testing during evaluation for a brain-death-compatible state. Temporal changes in the determination of a brain-death-compatible state, organ donation discussion, and critical care management were evaluated by calendar year, with three study phases (2017-2019, 2020-2022, and 2023-2025) used for descriptive presentation. Annual trends were assessed using logistic regression and nonparametric trend analyses.
RESULTS: Among 128 eligible patients, organ donation was discussed with the families of 110 (85.9%), and 41 (37.3%) subsequently underwent organ donation after brain death. Calendar-year analyses showed increasing corticosteroid use (odds ratio [OR] per year, 1.64; 95% confidence interval [CI] 1.34-2.01; p < 0.001) and earlier initiation of corticosteroids and vasopressin, whereas no significant trends were observed in vasopressin use or in the timing of determination of a brain-death-compatible state or the initial organ donation discussion. The likelihood of organ donation discussion increased significantly over time (OR per year, 1.44; 95% CI 1.17-1.79; p = 0.001) and remained significant in a sensitivity analysis restricted to patients in whom discussion was considered feasible (OR per year, 2.11; 95% CI 1.42-3.15; p < 0.001).
CONCLUSIONS: The opportunity for organ donation discussion increased over time among patients considered clinically brain dead, while the proportion of families consenting to donation remained relatively stable. This increase occurred alongside the progressive development of structured multidisciplinary processes, although their contribution to the observed temporal trend cannot be determined from this descriptive study.
参考来源
- Ueda Y, Yumoto T, Tokioka K, et al. Temporal changes in clinical practices for patients considered clinically brain dead: a single-center cohort study. J Intensive Care. 2026. PMID: 42870279. doi:10.1186/s40560-026-00944-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。